NLRP3 and thyroid gland carcinoma: In fact, NLRP3 has been shown to be differently regulated in several tumors from leukemia (increased), thyroid carcinoma (increased), lymphoid neoplasm diffuse large B cell Lymphoma (decreased), thymoma (decreased), and uterine carcinosarcoma (no changes), to mention a few.